Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean McElligott

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Law & Medicine|August 25, 2009
Addressing supply side barriers to introduction of new vaccines to the developing worldSean McElligott
The American Journal of Geriatric Pharmacotherapy|March 2, 2011
Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary diseaseAndrea Puig, Sean McElligott, Henry Bergquist, et al.
Pediatric Cardiology|September 6, 2013
Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac deathBrett R Anderson, Sean McElligott, Daniel Polsky, et al.
Journal of the American College of Cardiology|July 2, 2013
Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010Hiram Beltrán-Sánchez, Michael O Harhay, Meera M Harhay, et al.
Skinmed|July 15, 2017
Telangiectasia Macularis Eruptiva Perstans: Report of Three CasesGizem Tumer, Tiffany Jow, Sean McElligott, et al.
Annals of Internal Medicine|June 6, 2012
Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemiaPengxiang Li, Sean McElligott, Henry Bergquist, et al.
The Journal of Dermatological Treatment|July 16, 2019
Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumabKristian Reich, Peter Foley, Chenglong Han, et al.
Clinical Epidemiology|June 29, 2018
Young patients with risk factors prevalent in the elderly - differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registersMohammadhossein Hajiebrahimi, Marie Linder, David Hägg, et al.
Journal of Oncology Practice|January 2, 2013
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lungElizabeth A Handorf, Sean McElligott, Anil Vachani, et al.
Journal of Comparative Effectiveness Research|October 3, 2018
Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasisChris Cameron, Brian Hutton, Cheryl Druchok, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Law & Medicine|August 25, 2009
Addressing supply side barriers to introduction of new vaccines to the developing worldSean McElligott
The American Journal of Geriatric Pharmacotherapy|March 2, 2011
Albuterol and levalbuterol use and spending in Medicare beneficiaries with chronic obstructive pulmonary diseaseAndrea Puig, Sean McElligott, Henry Bergquist, et al.
Pediatric Cardiology|September 6, 2013
Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac deathBrett R Anderson, Sean McElligott, Daniel Polsky, et al.
Journal of the American College of Cardiology|July 2, 2013
Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010Hiram Beltrán-Sánchez, Michael O Harhay, Meera M Harhay, et al.
Skinmed|July 15, 2017
Telangiectasia Macularis Eruptiva Perstans: Report of Three CasesGizem Tumer, Tiffany Jow, Sean McElligott, et al.
Annals of Internal Medicine|June 6, 2012
Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemiaPengxiang Li, Sean McElligott, Henry Bergquist, et al.
The Journal of Dermatological Treatment|July 16, 2019
Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumabKristian Reich, Peter Foley, Chenglong Han, et al.
Clinical Epidemiology|June 29, 2018
Young patients with risk factors prevalent in the elderly - differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registersMohammadhossein Hajiebrahimi, Marie Linder, David Hägg, et al.
Journal of Oncology Practice|January 2, 2013
Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lungElizabeth A Handorf, Sean McElligott, Anil Vachani, et al.
Journal of Comparative Effectiveness Research|October 3, 2018
Importance of assessing and adjusting for cross-study heterogeneity in network meta-analysis: a case study of psoriasisChris Cameron, Brian Hutton, Cheryl Druchok, et al.
Pageof 2